Publication #7492
Reference
CEM/CMO/2021/011(U
Name
COVID therapeutic alert – withdrawal of the recommendation for consideration for inhaled budesonide as a treatment option for COVID-19
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Inhaled budesonide should no longer be considered as a treatment for individuals with COVID-19 infection other than within the context of a clinical trial. People already using budesonide for conditions other than COVID-19 should continue treatment if they test positive for COVID-19.
Contact Name
Contact Email
Contact Address
Contact Phone
Created
2021-12-14 00:00:00
Click to go back to homepage